KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Operating Expenses (2016 - 2026)

Chemed filings provide 18 years of Operating Expenses readings, the most recent being $572.9 million for Q1 2026.

  • For the quarter ending Q1 2026, Operating Expenses rose 3.76% year-over-year to $572.9 million, compared with a TTM value of $2.2 billion through Mar 2026, up 5.35%, and an annual FY2025 reading of $2.2 billion, up 6.15% over the prior year.
  • Operating Expenses hit $572.9 million in Q1 2026 for Chemed, up from $538.7 million in the prior quarter.
  • The five-year high for Operating Expenses was $572.9 million in Q1 2026, with the low at $439.4 million in Q2 2022.
  • Median Operating Expenses over the past 5 years was $507.8 million (2024), compared with a mean of $502.6 million.
  • The sharpest move saw Operating Expenses decreased 4.6% in 2022, then rose 10.87% in 2024.
  • Year by year, Operating Expenses stood at $465.3 million in 2022, then grew by 1.98% to $474.5 million in 2023, then rose by 10.87% to $526.1 million in 2024, then grew by 2.39% to $538.7 million in 2025, then rose by 6.36% to $572.9 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $572.9 million, $538.7 million, and $550.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.